Home Print this page Email this page
Users Online: 190
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 7  |  Issue : 1  |  Page : 45-50

Comparative analysis of extended-spectrum beta-lactamases producing uropathogens in outpatient and inpatient departments


Department of Microbiology, Dr. Baba Saheb Ambedkar Hospital, New Delhi, India

Correspondence Address:
Dr. Renu Gur
Department of Microbiology, Dr. Baba Saheb Ambedkar Hospital, Rohini, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijhas.IJHAS_33_17

Rights and Permissions

INTRODUCTION: Since its discovery in 1980, extended-spectrum beta-lactamases (ESBL) have been prevalent throughout the world. Several new and more complicated resistance mechanisms have emerged and have driven the focus away from ESBLs. The present study was conducted to know the isolated prevalence and resistance profile of ESBL-producing Gram-negative uropathogens and outline an empirical therapy for management of urinary tract infections. MATERIALS AND METHODS: A study was conducted over a period of 3 months (April to June 2015) in the microbiology department of our 500-bedded tertiary care referral hospital. Urine specimens were processed as per standard guidelines. Antimicrobial susceptibility and ESBL detection were performed by Kirby–Bauer Disc diffusion method and results were interpreted as per CLSI 2015 guidelines. Production of other beta-lactamases was not studied. Klebsiella pneumoniae ATCC 700603 (ESBL positive) and Escherichia coli ATCC 25922 (ESBL negative) strains were used as quality control. P <0.05 was considered statistically significant. RESULTS: Of the 111 Gram-negative urinary isolates, 60 were ESBL positive (54%). ESBL prevalence was highest in E. coli (73.3%), followed by Klebsiella spp. (11.7%), Morganella spp. (6.7), Proteus mirabilis (5%), Pseudomonas spp. (1.6%), and Citrobacter spp. (1.6%). Most of the ESBL isolates were from outpatient department (OPD) (76.7%) while only 23.3% were from inpatient department (IPD), P < 0.0001, which was extremely significant. When compared to IPD, OPD isolates were found to be more resistant to fluoroquinolones and cotrimoxazole. CONCLUSION: ESBLs can cause therapeutic failure even when host appears to be susceptible in vitro. Hence, it is important to know its prevalence and antimicrobial susceptibility profile to formulate appropriate antibiotic policy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1411    
    Printed16    
    Emailed0    
    PDF Downloaded267    
    Comments [Add]    
    Cited by others 1    

Recommend this journal